The Valley Desk

NCT00119314 · Interventional trial

Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin

Overall registry status Withdrawn

Phase 2

Conditions Carcinoma of Unknown Primary

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov